Intravenous Infusion
Showing 1 - 25 of >10,000
Duchenne Muscular Dystrophy Trial in Chengdu (JWK007 Single intravenous infusion administration)
Recruiting
- Duchenne Muscular Dystrophy
- JWK007 Single intravenous infusion administration
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Oct 29, 2023
Postoperative Analgesia Trial in Cairo (Intravenous lidocaine infusion, Erector spinae plane block (ESPB), Intravenous infusion
Not yet recruiting
- Postoperative Analgesia
- Intravenous lidocaine infusion
- +3 more
-
Cairo, EgyptAin-Shams University Hospitals
Oct 13, 2023
Acute Heart Failure, Congestion, Heart Failure Trial in Wroclaw (Furosemide intravenous infusion, Continous intravenous infusion
Recruiting
- Acute Heart Failure
- +2 more
- Furosemide intravenous infusion
- +2 more
-
Wroclaw, Lower Silesia, PolandInstitute of Heart Diseases, Wroclaw Medical University
Jul 23, 2023
Pediatric Cancer, Neutropenia, Lenograstim Trial in Taoyuan (G-CSF administration (bolus injection versus intravenous infusion))
Recruiting
- Pediatric Cancer
- +4 more
- G-CSF administration (bolus injection versus intravenous infusion)
-
Taoyuan, ROC, TaiwanChang Gung Children Hospital
Nov 21, 2023
Imfinzi/Imjudo uHCC Japan PMS _ Japan Post-Marketing
Not yet recruiting
- Unresectable Hepatocellular Carcinoma
- (no location specified)
Dec 19, 2022
Intravenous Infusion of Tramadol-ondansetron on Recovery After
Recruiting
- Post Operative Pain
- +8 more
- Tramadol-ondansetron continuous infusion
- Ropivacaine via epidural catheter
-
Valencia, SpainHospital Universitario La Fe
May 26, 2023
Fomepizole Intravenous Infusion (All-case Surveillance)
Completed
- Ethylene Glycol Poisoning, Methanol Poisoning
-
Osaka, Japan
- +1 more
Jul 12, 2022
Hepatitis B Trial (Undiluted I.V.-Hepabig inj(GC5103), Diluted I.V.-Hepabig inj(GC5103))
Not yet recruiting
- Hepatitis B
- Undiluted I.V.-Hepabig inj(GC5103)
- Diluted I.V.-Hepabig inj(GC5103)
- (no location specified)
Jan 19, 2023
Magnesium Sulfate, Labetalol Trial in Zagazig (Magnesium sulfate, Labetolol)
Completed
- Magnesium Sulfate
- Labetalol
- Magnesium sulfate
- Labetolol
-
Zagazig, Zagazig, Elsharkia,egypt, EgyptFaculty of Medicine,Zagazig University
Nov 13, 2022
Obinutuzumab, Rapid Infusion, Intravenous Infusion Reaction Trial in Nanjing (intravenous rapid infusion of obinutuzumab)
Recruiting
- Obinutuzumab
- +2 more
- intravenous rapid infusion of obinutuzumab
-
Nanjing, Jiangsu, ChinaJiangsu Province Hospital
Aug 18, 2022
Autism Trial in St. John's (AlloRx)
Recruiting
- Autism
- AlloRx
-
St. John's, Antigua and BarbudaMedical Surgical Associates Center
Oct 25, 2022
Septic Shock, Sepsis Trial in Cairo (Paracetamol, Normal saline)
Completed
- Septic Shock
- Sepsis
- Paracetamol
- Normal saline
-
Cairo, EgyptCairo University hospitals
Oct 10, 2023
Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory
Active, not recruiting
- Peripheral T Cell Lymphoma
- Pediatric Hodgkin Lymphoma
- Brentuximab Vedotin (Genetical Recombination)
-
Tokyo, JapanTakeda Selected Site
Oct 11, 2022
Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- (no location specified)
Apr 21, 2023
Safety and Efficacy of Trastuzumab BS
Not yet recruiting
- Gastric Cancer
- TRASTUZUMAB BS
- (no location specified)
Dec 19, 2022
ATGAM General Investigation
Not yet recruiting
- Aplastic Anemia
- Anti-human thymocyte immunoglobulin, equine
- (no location specified)
Sep 8, 2023
Diabetes Trial in St. John's (AlloRx)
Recruiting
- Diabetes
- AlloRx
-
St. John's, Antigua and Barbuda
- +2 more
Oct 21, 2022
Multiple Sclerosis Trial in St. John's (AlloRx)
Recruiting
- Multiple Sclerosis
- AlloRx
-
St. John's, Antigua and Barbuda
- +2 more
Oct 25, 2022
Rheumatoid Arthritis Trial in St. John's (AlloRx)
Recruiting
- Rheumatoid Arthritis
- AlloRx
-
St. John's, Antigua and Barbuda
- +2 more
Oct 25, 2022
IBD Trial in St. John's (AlloRx)
Recruiting
- Inflammatory Bowel Diseases
- AlloRx
-
St. John's, Antigua and Barbuda
- +2 more
Oct 25, 2022
Brentuximab Vedotin Intravenous Infusion "Untreated
Active, not recruiting
- Untreated CD30-Positive Hodgkin's Lymphoma
- Brentuximab vedotin (Genetical Recombination)
-
Tokyo, JapanTakeda Selected Site
Mar 24, 2022
Pulmonary Hypertension Due to Left Heart Disease Trial in Neu-Ulm (BAY2701250 IV, Placebo IV, BAY2701250 SC)
Recruiting
- Pulmonary Hypertension Due to Left Heart Disease
- BAY2701250 IV
- +3 more
-
Neu-Ulm, Bayern, GermanyNUVISAN GmbH Neu-Ulm
Sep 19, 2023